Faecalibacterium prausnitzii, a species within this genus, has been suggested as a therapeutic option for type 2 diabetes due to its potential to enhance insulin sensitivity, improve lipid metabolism, and reduce inflammation [65]. Here, INS is linked to type 2 diabetes mellitus.